Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sucampo Pharmaceuticals SCMP

Healthcare Drug Manufacturers - Specialty & Generic
"Sucampo Pharmaceuticals Inc is a part of the healthcare sector in the United States. As a global pharmaceutical company, it commercializes drugs for the treatment of various gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It currently generates revenue mainly from product royalties, product sales, upfront and milestone payments, and reimbursements for development... see more

Recent & Breaking News (NDAQ:SCMP)

Sucampo Reports Second Quarter 2015 Financial Results and Corporate Update

GlobeNewswire August 5, 2015

Sucampo Announces Second Quarter 2015 Earnings Call

GlobeNewswire July 22, 2015

Sucampo Announces Second Quarter 2015 Earnings Call

GlobeNewswire July 22, 2015

Sucampo Announces Webcast of Its Presentation at Cantor Fitzgerald's Inaugural Healthcare Conference

GlobeNewswire July 1, 2015

China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone)

GlobeNewswire June 15, 2015

Sucampo Announces Webcast of Its Presentation at the Jefferies 2015 Healthcare Conference

GlobeNewswire May 27, 2015

Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week

GlobeNewswire May 15, 2015

Sucampo Announces Webcast of Its Presentation at the 2015 UBS Global Healthcare Conference

GlobeNewswire May 13, 2015

Sucampo and Harbin Gloria Pharmaceuticals Enter Into Licensing Agreement for AMITIZA(R) (lubiprostone) in China

GlobeNewswire May 11, 2015

FDA Grants Fast Track Designation to Sucampo's Cobiprostone for Oral Mucositis

GlobeNewswire May 7, 2015

Sucampo Reports First Quarter 2015 Financial Results and Corporate Update

GlobeNewswire May 6, 2015

Sucampo Announces First Quarter 2015 Earnings Call

GlobeNewswire April 22, 2015

Sucampo Announces Webcast of Its Presentation at the 14th Annual Needham Healthcare Conference

GlobeNewswire April 7, 2015

Sucampo Prices Public Offering of Common Stock by Selling Stockholders

GlobeNewswire March 26, 2015

Sucampo Announces Proposed Public Offering by Selling Stockholders

GlobeNewswire March 25, 2015

Sucampo to Return All Licenses for Unoprostone Isopropyl to R-Tech Ueno

GlobeNewswire March 9, 2015

Sucampo Reports Fourth Quarter and Full Year 2014 Financial Results and Corporate Update

GlobeNewswire March 4, 2015

Sucampo Announces Webcast of Its Presentation at the 27th Annual ROTH Conference

GlobeNewswire March 3, 2015

Sucampo Announces Webcast of Its Presentation at the 2015 Cowen and Company Healthcare Conference

GlobeNewswire February 22, 2015

Sucampo Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2014 Earnings Call

GlobeNewswire February 18, 2015